SCHEMBL8987230

SCHEMBL8987230

O=C(CC(=O)c1ccc(F)cc1)Nc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 10/20 0.63
MEN1 O00255 8/20 0.63
NPC1 O15118 6/20 0.61
RAB9A P51151 5/20 0.61
POLB P06746 3/20 0.57
ALDH1A1 P00352 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
PKM P14618 1/20 0.56
TP53 P04637 1/20 0.55
ATM Q13315 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.53
KCNK3 O14649 1/20 0.53
KCNK9 Q9NPC2 1/20 0.53
MAPT P10636 1/20 0.53
HPGD P15428 1/20 0.53
ALOX12 P18054 1/20 0.53
HTT P42858 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
LMNA P02545 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11572863 0.91 RAB9A (0.71) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL1098345 0.87 RAB9A (0.77) KMT2AMEN1NPC1RAB9APOLB
SCHEMBL21424286 0.87 KMT2A (0.73) KMT2AMEN1POLBL3MBTL1TP53
SCHEMBL14890950 0.85 RAB9A (0.74) KMT2AMEN1NPC1RAB9APOLB
SCHEMBL9508626 0.84 KMT2A (0.63) KMT2AMEN1NPC1RAB9APOLB
SCHEMBL11795069 0.84 RAB9A (0.68) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL11782142 0.83 KMT2A (0.83) KMT2AMEN1NPC1RAB9APOLB
SCHEMBL25986986 0.83 SMN1; SMN2 (0.65) KMT2AMEN1NPC1RAB9APOLB
SCHEMBL5931312 0.83 MEN1 (0.54) KMT2AMEN1NPC1RAB9APOLB
SCHEMBL11135996 0.83 KMT2A (0.71) KMT2AMEN1NPC1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5492915-A ANTIINFLAMMATORY AGENTS RHONE-POULENC RORER S.A. (FR) 1996-02-20 US disclosed
US-5366982-A Antiinflammatory agents or antihistamines RHONE-POULENC RORER S.A. (FR) 1994-11-22 US disclosed
EP-0540604-A1 SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B 4? ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS Aventis Pharma S.A. (FR) 1993-05-12 EP disclosed
WO-1992001675-A2 SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B4 ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS RHONE-POULENC RORER S.A. (FR) 1992-02-06 WO disclosed
US-4758566-A 2-(1-piperazinyl)-4-substituted phenylquinoline derivatives, processes for the preparation thereof, and pharmaceutical composition containing the same DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1988-07-19 US disclosed
EP-0204003-A1 2-(1-PIPERAZINYL)-4-SUBSTITUTED PHENYLQUINOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND MEDICINAL COMPOSITION CONTAINING SAME Dainippon Pharmaceutical Co., Ltd. (JP) 1986-12-10 EP disclosed